Using deep learning to annotate the protein universe ML Bileschi, D Belanger, DH Bryant, T Sanderson, B Carter, D Sculley, ... Nature Biotechnology, 1-6, 2022 | 243 | 2022 |
Antibody complementarity determining region design using high-capacity machine learning G Liu, H Zeng, J Mueller, B Carter, Z Wang, J Schilz, G Horny, ... Bioinformatics 36 (7), 2126-2133, 2020 | 147 | 2020 |
What made you do this? Understanding black-box decisions with sufficient input subsets B Carter, J Mueller, S Jain, D Gifford The 22nd International Conference on Artificial Intelligence and Statistics …, 2019 | 77* | 2019 |
Lost in pruning: The effects of pruning neural networks beyond test accuracy L Liebenwein, C Baykal, B Carter, D Gifford, D Rus Proceedings of Machine Learning and Systems 3, 2021 | 73 | 2021 |
Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions G Liu, B Carter, T Bricken, S Jain, M Viard, M Carrington, DK Gifford Cell Systems 11 (2), 131-144. e6, 2020 | 65 | 2020 |
Embedding comparator: Visualizing differences in global structure and local neighborhoods via small multiples A Boggust, B Carter, A Satyanarayan 27th International Conference on Intelligent User Interfaces, 746-766, 2022 | 56 | 2022 |
Overinterpretation reveals image classification model pathologies B Carter, S Jain, JW Mueller, D Gifford Advances in Neural Information Processing Systems 34, 2021 | 52 | 2021 |
Predicted cellular immunity population coverage gaps for SARS-CoV-2 subunit vaccines and their augmentation by compact peptide sets G Liu, B Carter, DK Gifford Cell Systems 12 (1), 102-107. e4, 2021 | 47 | 2021 |
Machine learning optimization of peptides for presentation by class II MHCs Z Dai, BD Huisman, H Zeng, B Carter, S Jain, ME Birnbaum, DK Gifford Bioinformatics 37 (19), 3160-3167, 2021 | 13 | 2021 |
Critiquing protein family classification models using sufficient input subsets B Carter, M Bileschi, J Smith, T Sanderson, D Bryant, D Belanger, ... Journal of Computational Biology 27 (8), 1219-1231, 2020 | 10 | 2020 |
Maximum n-times Coverage for Vaccine Design G Liu, A Dimitrakakis, B Carter, D Gifford arXiv preprint arXiv:2101.10902, 2021 | 8 | 2021 |
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta B Carter, P Huang, G Liu, Y Liang, PJC Lin, BH Peng, LGA McKay, ... Frontiers in Immunology 14, 710, 2023 | 7 | 2023 |
Safety and efficacy of ganciclovir ophthalmic gel for treatment of adenovirus keratoconjunctivitis utilizing cell culture and animal models SP Epstein, KB Fernandez, BM Carter, SA Abdou, N Gadaria, PA Asbell Investigative Ophthalmology & Visual Science 53 (14), 6203-6203, 2012 | 4 | 2012 |
Survey of Fully Verifiable Voting Cryptoschemes B Carter, K Leidal, D Neal, Z Neely | 2 | 2016 |
Preliminary Immunogenicity of a Pan-COVID-19 T Cell Vaccine in HLA-A* 02: 01 Mice B Carter, J Chen, C Kaseke, A Dimitrakakis, GD Gaiha, Q Xu, DK Gifford bioRxiv, 2021.05. 02.442052, 2021 | 1 | 2021 |
Machine learning model interpretations explain T cell receptor binding B Carter, J Krog, ME Birnbaum, DK Gifford bioRxiv, 2023.08. 15.553228, 2023 | | 2023 |
Interpretations of Machine Learning and Their Application to Therapeutic Design BM Carter Massachusetts Institute of Technology, 2023 | | 2023 |
Interpreting black-box models through sufficient input subsets BM Carter Massachusetts Institute of Technology, 2019 | | 2019 |
Local and global model interpretability via backward selection and clustering B Carter, J Mueller, S Jain, D Gifford | | 2018 |
Fast-Fi: Designing Large Throughput-Optimized Wireless Networks B Carter, G Mirano, H Zhou | | 2016 |